Proinflammatory mediators and genetic background in oncogene mediated tumor progression

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• RET/PTC3 (RP3) is an oncogenic fusion protein found in papillary thyroid carcinomas and Hashimoto's thyroiditis.
• Constitutive activation of RP3's tyrosine kinase domain triggers signaling pathways and cellular transformation in thyrocytes.
• RP3 activates NF-kappaB, leading to immunostimulatory factors like GM-CSF and macrophage chemotactic protein 1, suggesting RP3 acts as a molecular adjuvant.

Purpose of the Study:

• To investigate the in vivo production of proinflammatory mediators in RP3-transgenic mouse thyroids.
• To assess the influence of genetic background on RP3-induced inflammation and tumor progression.
• To validate in vitro findings regarding RP3's role in activating cytokine secretion and promoting thyroid cancer development.

Main Methods:

• Analysis of proinflammatory mediator production in thyroid organs of RP3-transgenic and nontransgenic mice.
• Assessment of cytokine (Il1alpha, Il1beta, Il6, Tnfalpha) and Cox2 expression in thyroid tissue.
• Evaluation of tumor progression and inflammation in relation to host genetic background.

Main Results:

• RP3-transgenic thyroid tissue produced Il1alpha, Il1beta, Il6, Tnfalpha, and Cox2, which were absent in nontransgenic thyroids.
• In vivo findings were consistent with in vitro studies showing RP3-induced cytokine production.
• Host genetic background significantly impacted RP3-induced inflammation and thyroid tumor progression.

Conclusions:

• Oncogene-induced cytokine secretion is crucial for the development and progression of thyroid carcinomas.
• RP3 promotes thyroid inflammation and tumor growth through the activation of specific signaling pathways.
• Genetic background plays a critical role in mediating the effects of oncogenes in thyroid cancer development.